Localized scleroderma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Peterson, 1995, Subspecialty clinics: rheumatology and dermatology classification of morphea (localized scleroderma), Mayo Clin Proc, 70, 1068, 10.4065/70.11.1068
Zulian, 2006, Juvenile localized scleroderma: clinical and epidemiological features in 750 children: an international study, Rheumatology (Oxford), 45, 614, 10.1093/rheumatology/kei251
Appelhans, 2006, Unilateral generalized morphea is a rare variant of localized scleroderma, Eur J Med Res, 11, 152
Jablonska, 2005, Long-lasting follow-up favours a close relationship between progressive facial hemiatrophy and scleroderma en coup de sabre, J Eur Acad Dermatol Venereol, 19, 403, 10.1111/j.1468-3083.2005.00979.x
Menni, 1997, Neurologic abnormalities in two patients with facial hemiathrophy and sclerosis coexisting with morphea, Pediatr Dermatol, 14, 113, 10.1111/j.1525-1470.1997.tb00216.x
Blaszczyk, 1999, Linear scleroderma en coup de sabre: relationship with progressive facial hemiatrophy, Adv Exp Med Biol, 455, 101, 10.1007/978-1-4615-4857-7_14
Sommer, 2006, Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients, J Am Acad Dermatol, 54, 227, 10.1016/j.jaad.2005.10.020
Wollina, 2002, Squamous cell carcinoma in pansclerotic morphea of childhood, Pediatr Dermatol, 19, 151, 10.1046/j.1525-1470.2002.00033.x
Parodi, 2001, Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea, Br J Dermatol, 144, 417, 10.1046/j.1365-2133.2001.04041.x
Maragh, 2005, Disabling pansclerotic morphea: clinical presentation in two adults, J Am Acad Dermatol, 53, S115, 10.1016/j.jaad.2004.10.881
Dehen, 1994, Internal involvement in localized scleroderma, Medicine (Baltimore), 73, 241, 10.1097/00005792-199409000-00002
Zulian, 2005, Localized scleroderma in childhood is not just a skin disease, Arthritis Rheum, 52, 2873, 10.1002/art.21264
Blaszczyk, 2003, Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre, J Rheumatol, 30, 1997
Sathornsumetee, 2005, Parry-Romberg syndrome with fatal brain stem involvement, J Pediatr, 146, 429, 10.1016/j.jpeds.2004.10.026
DeFelipe, 2001, Neuropathological findings in a patient with epilepsy and the Parry-Romberg syndrome, Epilepsia, 42, 1198, 10.1046/j.1528-1157.2001.45800.x
Flores-Alvarado, 2003, Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship?, J Rheumatol, 30, 193
Holland, 2006, Linear scleroderma en coup de sabre with associated neurologic abnormalities, Pediatrics, 117, 132, 10.1542/peds.2005-0470
Weber, 2000, Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease, J Rheumatol, 27, 2692
Peterson, 1997, The epidemiology of morphea (localized scleroderma) in Olmsted County, J Rheumatol, 24, 73
Uziel, 1994, Localized scleroderma in childhood: a report of 30 cases, Semin Arthritis Rheum, 23, 328, 10.1016/0049-0172(94)90028-0
Vancheeswaran, 1996, Childhood onset scleroderma: is it different from adult onset disease, Arthritis Rheum, 39, 1041, 10.1002/art.1780390624
Marzano, 2003, Localized scleroderma in adults and children: clinical and laboratory investigations on 239 cases, Eur J Dermatol, 13, 171
Aberer, 1985, Is localised scleroderma a Borrelia infection?, Lancet, 2, 278, 10.1016/S0140-6736(85)90329-0
Fan, 1995, Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea), J Am Acad Dermatol, 33, 682, 10.1016/0190-9622(95)91311-4
Reddy, 2005, Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review, Semin Arthritis Rheum, 34, 728, 10.1016/j.semarthrit.2004.11.004
Ludwig, 2006, Chronic venous insufficiency: a potential trigger for localized scleroderma, J Eur Acad Dermatol Venereol, 20, 96, 10.1111/j.1468-3083.2005.01359.x
Tan, 1997, Range of antinuclear antibodies in ‘healthy’ individuals, Arthritis Rheum, 40, 1601, 10.1002/art.1780400909
Newkirk, 2002, Rheumatoid factors: what do they tell us?, J Rheumatol, 29, 2034
Vila, 1994, Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects, Thromb Haemost, 72, 209, 10.1055/s-0038-1648840
Blaszczyk, 2000, Relationship between cutaneous and systemic scleroderma: are immunopathological studies helpful in evaluating transition of cutaneous to systemic scleroderma?, Przeglad Dermatologiczny, 2, 119
Takehara, 2005, Localized scleroderma is an autoimmune disease, Rheumatology (Oxford), 44, 274, 10.1093/rheumatology/keh487
Ruffatti, 1986, Anticentromere antibody in localized scleroderma, J Am Acad Dermatol, 15, 637, 10.1016/S0190-9622(86)70217-X
Mimura, 2005, Rheumatoid factor isotypes in localized scleroderma, Clin Exp Dermatol, 30, 405, 10.1111/j.1365-2230.2005.01776.x
el Azhary, 2004, Do antihistone autoantibodies reflect disease activity in linear scleroderma?, Arch Dermatol, 140, 759, 10.1001/archderm.140.6.759
Hayakawa, 2004, Anti-DNA topoisomerase IIα autoantibodies in localised scleroderma, Arthritis Rheum, 50, 227, 10.1002/art.11432
Grigolo, 1998, Mapping of topoisomerase IIα epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis, Clin Exp Immunol, 114, 339, 10.1046/j.1365-2249.1998.00747.x
Sato, 2003, Antiphospholipid antibody in localised scleroderma, Ann Rheum Dis, 62, 771, 10.1136/ard.62.8.771
Vila, 1994, Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects, Thromb Haemost, 72, 209, 10.1055/s-0038-1648840
Hasegawa, 2006, Antiphosphatidylserine–prothrombin complex antibodies in patients with localized scleroderma, Clin Exp Rheumatol, 24, 19
Hasegawa, 2003, Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma, Dermatology, 207, 141, 10.1159/000071783
Martini, 2002, Juvenile-onset localized scleroderma activity detection by infrared thermography, Rheumatology (Oxford), 41, 1178, 10.1093/rheumatology/41.10.1178
Zulian, 2006, Computerized skin score: a new technique for the assessment of localized scleroderma [abstract]. Proceedings of the Annual European Congress of Rheumatology EULAR 2006; 21-24 June 2006; Amsterdam, The Netherlands., Ann Rheum Dis, 65, 578
Cosnes, 2003, Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma, Br J Dermatol, 148, 724, 10.1046/j.1365-2133.2003.05289.x
Dytoc, 2005, First case series on the use of imiquimod for morphoea, Br J Dermatol, 153, 815, 10.1111/j.1365-2133.2005.06776.x
Kreuter, 2005, Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma, Arch Dermatol, 141, 847, 10.1001/archderm.141.7.847
Uziel, 2000, Methotrexate and corticosteroid therapy for pediatric localized scleroderma, J Pediatr, 136, 91, 10.1016/S0022-3476(00)90056-8
Fitch, 2006, Treatment of pediatric localized scleroderma with methotrexate, J Rheumatol, 33, 609
El-Mofty, 2004, Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study, Photodermatol Photoimmunol Photomed, 20, 93, 10.1111/j.1600-0781.2004.00080.x
Kreuter, 2006, A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma, J Am Acad Dermatol, 54, 440, 10.1016/j.jaad.2005.11.1063
Rose, 2005, Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea, Clin Exp Dermatol, 30, 226, 10.1111/j.1365-2230.2004.01693.x